Literature DB >> 23183834

Transplantation: Are calcineurin inhibitors safer than mTOR inhibitors?

Heidi Yeh1, James F Markmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23183834      PMCID： PMC3951270          DOI： 10.1038/nrneph.2012.262

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.

Authors:  Sudhir S Kushwaha; Zain Khalpey; Robert P Frantz; Richard J Rodeheffer; Alfredo L Clavell; Richard C Daly; Christopher G McGregor; Brooks S Edwards
Journal:  J Heart Lung Transplant       Date:  2005-12       Impact factor: 10.247

2.  Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation.

Authors:  T Isakova; H Xie; S Messinger; F Cortazar; J J Scialla; G Guerra; G Contreras; D Roth; G W Burke; M Z Molnar; I Mucsi; M Wolf
Journal:  Am J Transplant       Date:  2012-10-01       Impact factor: 8.086

3.  Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells.

Authors:  W Lieberthal; R Fuhro; C C Andry; H Rennke; V E Abernathy; J S Koh; R Valeri; J S Levine
Journal:  Am J Physiol Renal Physiol       Date:  2001-10

4.  The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients.

Authors:  S M Flechner; M Glyda; S Cockfield; J Grinyó; Ch Legendre; G Russ; S Steinberg; K M Wissing; S S Tai
Journal:  Am J Transplant       Date:  2011-06-10       Impact factor: 8.086

Review 5.  Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials.

Authors:  Angela C Webster; Vincent W S Lee; Jeremy R Chapman; Jonathan C Craig
Journal:  Transplantation       Date:  2006-05-15       Impact factor: 4.939

Review 6.  The role of the mammalian target of rapamycin (mTOR) in renal disease.

Authors:  Wilfred Lieberthal; Jerrold S Levine
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

7.  Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation.

Authors:  Ryan A McTaggart; Danielle Gottlieb; Jessica Brooks; Peter Bacchetti; John P Roberts; Stephen Tomlanovich; Sandy Feng
Journal:  Am J Transplant       Date:  2003-04       Impact factor: 8.086

8.  Chronic renal failure after transplantation of a nonrenal organ.

Authors:  Akinlolu O Ojo; Philip J Held; Friedrich K Port; Robert A Wolfe; Alan B Leichtman; Eric W Young; Julie Arndorfer; Laura Christensen; Robert M Merion
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

9.  Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster.

Authors:  Ivana Bjedov; Janne M Toivonen; Fiona Kerr; Cathy Slack; Jake Jacobson; Andrea Foley; Linda Partridge
Journal:  Cell Metab       Date:  2010-01       Impact factor: 27.287

10.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.

Authors:  David E Harrison; Randy Strong; Zelton Dave Sharp; James F Nelson; Clinton M Astle; Kevin Flurkey; Nancy L Nadon; J Erby Wilkinson; Krystyna Frenkel; Christy S Carter; Marco Pahor; Martin A Javors; Elizabeth Fernandez; Richard A Miller
Journal:  Nature       Date:  2009-07-08       Impact factor: 49.962
  10 in total
  3 in total

Review 1.  Calcineurin-NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy.

Authors:  Kamila Bendickova; Federico Tidu; Jan Fric
Journal:  EMBO Mol Med       Date:  2017-08       Impact factor: 12.137

Review 2.  Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases.

Authors:  Jae-Ung Lee; Li-Kyung Kim; Je-Min Choi
Journal:  Front Immunol       Date:  2018-11-27       Impact factor: 7.561

3.  Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease.

Authors:  Florian Uellendahl-Werth; Carlo Maj; Oleg Borisov; Simonas Juzenas; Eike Matthias Wacker; Isabella Friis Jørgensen; Tim Alexander Steiert; Saptarshi Bej; Peter Krawitz; Per Hoffmann; Christoph Schramm; Olaf Wolkenhauer; Karina Banasik; Søren Brunak; Stefan Schreiber; Tom Hemming Karlsen; Franziska Degenhardt; Markus Nöthen; Andre Franke; Trine Folseraas; David Ellinghaus
Journal:  Commun Biol       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.